| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| September 16th, 2008 | 18 | Yes |
Popular Name: Albendazole Albendazole
Find On: PubMed — Wikipedia — Google
CAS Numbers: 54965-21-8 , [54965-21-8]
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French]
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
5-(Propylthio)-2-carbomethoxyaminobenzimidazole
54965-21-8; Albendazole (JAN/USP/INN); Albenza (TN); D00134
54965-21-8; Albendazole; C01779
54965-21-8; Albendazole; CPD000036735; SAM002589939
54965-21-8; Albendazole; Prestwick_675
Albendazole Noe-Socopharm Brand
Albendazole [USAN:INN:BAN:JAN]
Albendazole, Antibiotic for Culture Media Use Only
Albendazole; CPD000036735; SAM002589939
Albenza, Eskazole, Zentel, Andazol
Albenza, Eskazole, Zentel, Andazol, Albendazole
Armstrong Brand of Albendazole
CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER
Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester
CHEBI:13751; CHEBI:22286; CHEBI:2545
Methyl 5-(propyl-thio)-2-benzimidazolecarbamate
Methyl 5-(propylthio)-2-benzimidazolecarbamate
Methyl 5-n-propylthio-2-benzimidazolecarbamate
methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate
methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate
methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate
Methyl [5-(Propylthio)Benzimidazol-2-yl]Carbamate
methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
Methyl-5-[propylthio]-2-benzimidazole carbamate
Monohydrochloride, Albendazole
Noe Socopharm Brand of Albendazole
Noe-Socopharm Brand of Albendazole
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
Sanicoopa Brand of Albendazole
Smith Kline & French Brand of Albendazole
SmithKline Beecham Brand of Albendazole
Valdecasas Brand of Albendazole
[5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester
[5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 2.92 | 5.45 | -8.46 | 2 | 5 | 0 | 70 | 265.338 | 4 | ↓ |
| Ref Reference (pH 7) | 2.92 | 5.45 | -9.77 | 2 | 5 | 0 | 70 | 265.338 | 4 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| mechanism | . | ZereneX Building Blocks |
| ALOGPS_SOLUBILITY | 2.28e-02 g/l | DrugBank-approved |
| Melting_Point | 208-210? | Alfa-Aesar |
| Melting_Point | 208-210° | Alfa-Aesar |
| MP | 210 | TCI |
| MP | 215 - 217 | Enamine Building Blocks |
| MP | 215...217 | Enamine Building Blocks |
| purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
| Indications | anthelmintic | KeyOrganics Bioactives |
| biological_use | Anthelmintic. | IBScreen Bioactives |
| biological_use | Anthelmintic. Investigated for treatment of chronic stronglyoidiasis, and for microsporidiosis in AIDS patients | ZereneX Building Blocks |
| mechanism | Causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, | IBScreen Bioactives |
| UniProt Database Links | CP3A4_HUMAN; Y1708_MYCTU; Y2345_MYCTU; Y3660_MYCTU; Y3835_MYCTU | ChEBI |
| mechanism | Degenerative changes in the endoplasmic reticulum, the mitochondria of the germinal layer, and the subsequent release of lysosomes result in decreased production of adenosine triphosphate (ATP), | IBScreen Bioactives |
| mechanism | Due to diminished energy production, the parasite is immobilized and eventually dies | IBScreen Bioactives |
| biological_use | Investigated for treatment of chronic stronglyoidiasis, and for microsporidiosis in AIDS patients | IBScreen Bioactives |
| Target | Microtubule Associated | Selleck Chemicals |
| PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : A-7346; NCC_SUPPLIER_SAMPLE_COMMENTS : OFF-WHITE POWDER | NIH Clinical Collection via PubChem |
| Target | Others | Selleck Chemicals |
| PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: A-7346; SUPPLIER_COMMENTS: OFF-WHITE POWDER | NIH Clinical Collection via PubChem |
| mechanism | The loss of the cytoplasmic microtubules leads to impaired uptake of glucose by the larval and adult stages of the susceptible parasites, and depletes their glycogen stores. | IBScreen Bioactives |
| mechanism | thus inhibiting its polymerization or assembly into microtubules. | IBScreen Bioactives |
| Patent Database Links | US2003105066; US2004254182; US2006222684; US2007208134; US2008194694; US2008255073; WO2006134466 | ChEBI |
| Purity | USP24 | APIChem |
| mechanism | which is the energy required for the survival of the helminth. | IBScreen Bioactives |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| Z100715-2-O | Nippostrongylus Brasiliensis (cluster #2 Of 2), Other | Other | 340 | 0.50 | Functional ≤ 10μM |
| Z50467-2-O | Trichomonas Vaginalis (cluster #2 Of 3), Other | Other | 1592 | 0.45 | Functional ≤ 10μM |
| Z50468-2-O | Giardia Intestinalis (cluster #2 Of 4), Other | Other | 37 | 0.58 | Functional ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| Z50468 | Z50468 | Giardia Intestinalis | 37 | 0.58 | Functional ≤ 10μM |
| Z100715 | Z100715 | Nippostrongylus Brasiliensis | 340 | 0.50 | Functional ≤ 10μM |
| Z50467 | Z50467 | Trichomonas Vaginalis | 1590.5 | 0.45 | Functional ≤ 10μM |